Fred H Drake

Title: Fred H Drake: Innovator in Osteoclast Research

Introduction

Fred H Drake is a notable inventor based in Glenmore, PA (US). He has made significant contributions to the field of biomedical research, particularly in the study of osteoclasts and their role in bone diseases. With a total of 10 patents to his name, Drake's work has the potential to impact therapeutic approaches for conditions such as osteoporosis and cancer.

Latest Patents

One of his latest patents involves a human osteoclast-derived cathepsin, known as Cathepsin O. This invention discloses a polypeptide and the DNA (RNA) encoding such cathepsin O polypeptides. Additionally, the patent outlines a procedure for producing this polypeptide using recombinant techniques. The invention also includes antibodies, antagonists, and inhibitors of the polypeptide, which may be utilized therapeutically to prevent the action of Cathepsin O. This has implications for treating bone diseases and cancers, including tumor metastases.

Career Highlights

Throughout his career, Fred H Drake has worked with various organizations, including Human Genome Sciences, Inc. His innovative research has led to advancements in understanding the mechanisms of bone resorption and the development of potential treatments for related diseases.

Collaborations

Drake has collaborated with notable colleagues such as Gregg A Hastings and Mark D Adams. These partnerships have contributed to the depth and breadth of his research endeavors.

Conclusion

Fred H Drake's contributions to the field of osteoclast research and his innovative patents position him as a significant figure in biomedical science. His work continues to pave the way for new therapeutic strategies in treating bone diseases and cancers.